{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:39:10Z","timestamp":1768016350490,"version":"3.49.0"},"reference-count":231,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":6737,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.pbiomolbio.2005.05.011","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T11:43:59Z","timestamp":1118835839000},"page":"163-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["ACE2: A novel therapeutic target for cardiovascular diseases"],"prefix":"10.1016","volume":"91","author":[{"given":"Shant","family":"Der Sarkissian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Huentelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Katovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan K.","family":"Raizada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib2","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.HYP.30.2.217","article-title":"Angiotensin-(1\u20137) induces bradykinin-mediated hypotensive responses in anesthetized rats","volume":"30","author":"Abbas","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib5","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2174\/1381612033453758","article-title":"Therapeutic applications of human heme oxygenase gene transfer and gene therapy","volume":"9","author":"Abraham","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1196\/annals.1302.023","article-title":"Genetically engineered stem cell therapy for tissue regeneration","volume":"1015","author":"Alessandri","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib7","doi-asserted-by":"crossref","first-page":"F841","DOI":"10.1152\/ajprenal.2000.279.5.F841","article-title":"Pathways for angiotensin-(1\u20137) metabolism in pulmonary and renal tissues","volume":"279","author":"Allred","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib8","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.0000092888.63239.54","article-title":"Cardiac angiotensin-(1\u20137) in ischemic cardiomyopathy","volume":"108","author":"Averill","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000073606","article-title":"Gene therapy for bypass graft failure and restenosis","volume":"32","author":"Baker","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.RES.88.3.298","article-title":"Canine ventricular myocytes possess a renin\u2013angiotensin system that is upregulated with heart failure","volume":"88","author":"Barlucchi","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib11","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/nar\/25.14.2723","article-title":"Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential","volume":"25","author":"Baron","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjhyper.2004.02.022","article-title":"No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension","volume":"17","author":"Benjafield","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib13","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1\u20137) in spontaneously hypertensive rats","volume":"269","author":"Benter","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/j.1552-4604.1997.tb04767.x","article-title":"Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide","volume":"37","author":"Benz","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib15","first-page":"339","article-title":"Current concepts of silent myocardial ischemia","volume":"9","author":"Bleske","year":"1990","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.coph.2004.04.007","article-title":"High-throughput X-ray crystallography for drug discovery","volume":"4","author":"Blundell","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.HYP.31.1.181","article-title":"Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis","volume":"31","author":"Border","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198209093071104","article-title":"Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease","volume":"307","author":"Brenner","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/ki.1996.481","article-title":"Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group","volume":"50","author":"Breyer","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.69.1.107","article-title":"Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries","volume":"69","author":"Brilla","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","article-title":"Angiotensin-(1\u20137) dilates canine coronary arteries through kinins and nitric oxide","volume":"27","author":"Brosnihan","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib23","first-page":"227","article-title":"Angiotensin-(1\u20137): a novel vasodilator of the coronary circulation","volume":"31","author":"Brosnihan","year":"1998","journal-title":"Biol. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/01.HYP.0000085220.53285.11","article-title":"Enhanced renal immunocytochemical expression of ANG-(1\u20137) and ACE2 during pregnancy","volume":"42","author":"Brosnihan","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1590\/S0100-879X2004000800017","article-title":"Enhanced expression of Ang-(1\u20137) during pregnancy","volume":"37","author":"Brosnihan","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"issue":"Suppl. 7","key":"10.1016\/j.pbiomolbio.2005.05.011_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-198706107-00002","article-title":"Tissue renin\u2013angiotensin system: sites of angiotensin formation","volume":"10","author":"Campbell","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/cs0990255","article-title":"Science, art and drug discovery: a personal perspective","volume":"99","author":"Campbell","year":"2000","journal-title":"Clin. Sci. (London)"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/j.1552-4604.1997.tb04788.x","article-title":"Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough","volume":"37","author":"Chan","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/phrs.1997.0179","article-title":"Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases","volume":"35","author":"Chao","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"Suppl.","key":"10.1016\/j.pbiomolbio.2005.05.011_bib31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.4490555","article-title":"Differential actions of angiotensin-(1\u20137) in the kidney","volume":"68","author":"Chappell","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1\u20137) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.35.1.348","article-title":"Release of angiotensin-(1\u20137) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition","volume":"35","author":"Chappell","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11906-000-0065-4","article-title":"Gene therapy of hypertensive vascular injury","volume":"2","author":"Chu","year":"2000","journal-title":"Curr. Hypertens Rep."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.HYP.37.4.1141","article-title":"Angiotensin-(1\u20137) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"37","author":"Clark","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1071-9164(99)90038-6","article-title":"Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure","volume":"5","author":"Cohn","year":"1999","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1152\/physiolgenomics.00135.2002","article-title":"Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo","volume":"12","author":"Coleman","year":"2003","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib3","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1152\/physrev.1992.72.1.231","article-title":"Long-term control of arterial blood pressure","volume":"72","author":"Cowley","year":"1992","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0005-2744(71)90142-2","article-title":"Concentrations of angiotensin-converting enzyme in tissues of the rat","volume":"250","author":"Cushman","year":"1971","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib41","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids","volume":"16","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib42","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/hrt.76.3_Suppl_3.28","article-title":"Is there an internal cardiac renin\u2013angiotensin system?","volume":"76","author":"Danser","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1139\/y05-001","article-title":"Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage","volume":"83","author":"Deblois","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib45","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.HYP.31.4.912","article-title":"N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1\u20137) and keto-ACE","volume":"31","author":"Deddish","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib46","first-page":"415","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib47","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1089\/104303403322168028","article-title":"In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors","volume":"14","author":"De Palma","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0008-6363(02)00789-7","article-title":"Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril","volume":"57","author":"Der Sarkissian","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib49","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/sj.bjp.0705830","article-title":"Synergistic interaction between enalapril, l-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR","volume":"142","author":"Der Sarkissian","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.HYP.0000113047.47711.fa","article-title":"The sympathetic nervous system and hypertension: recent developments","volume":"43","author":"DiBona","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.HYP.30.5.1029","article-title":"Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats","volume":"30","author":"Diez","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-2828(03)00136-6","article-title":"Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy","volume":"35","author":"Dishart","year":"2003","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0162-3109(99)00121-6","article-title":"Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats","volume":"44","author":"Dobrzynski","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib55","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/01.HYP.36.6.995","article-title":"Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats","volume":"36","author":"Dobrzynski","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cardiores.2003.11.029","article-title":"Vascular chymase: pathophysiological role and therapeutic potential of inhibition","volume":"61","author":"Doggrell","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/01.HYP.35.1.164","article-title":"Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies","volume":"35","author":"Dominiczak","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib58","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.RES.88.3.275","article-title":"Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension","volume":"88","author":"Duka","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib60","doi-asserted-by":"crossref","first-page":"59A","DOI":"10.1016\/0002-9149(87)90178-0","article-title":"Implications of local angiotensin production in cardiovascular physiology and pharmacology","volume":"59","author":"Dzau","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib61","doi-asserted-by":"crossref","first-page":"334S","DOI":"10.1093\/ajh\/1.4.334S","article-title":"Evolving concepts of the renin-angiotensin system. Focus on renal and vascular mechanisms","volume":"1","author":"Dzau","year":"1988","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib62","doi-asserted-by":"crossref","first-page":"1L","DOI":"10.1016\/S0002-9149(01)01878-1","article-title":"The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data","volume":"88","author":"Dzau","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib63","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bjp.0704155","article-title":"Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions","volume":"133","author":"Emanueli","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib64","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1381612033391315","article-title":"Human tissue kallikrein: a new bullet for the treatment of ischemia","volume":"9","author":"Emanuelia","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib65","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1172\/JCI119419","article-title":"The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice","volume":"99","author":"Esther","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1440-1681.1990.tb01326.x","article-title":"Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure","volume":"17","author":"Fabris","year":"1990","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.25.2.219","article-title":"Cellular distribution of angiotensin-converting enzyme after myocardial infarction","volume":"25","author":"Falkenhahn","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.gt.3301633","article-title":"Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension","volume":"9","author":"Fennell","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib69","first-page":"278","article-title":"Angiotension-(1\u20137) and antihypertensive mechanisms","volume":"11","author":"Ferrario","year":"1998","journal-title":"J. Nephrol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib70","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.HYP.0000060688.57053.7E","article-title":"Commentary on Tikellis et al: There is more to discover about angiotensin-converting enzyme","volume":"41","author":"Ferrario","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib72","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1523-1755.2002.kid559.x","article-title":"Vasopeptidase inhibition and Ang-(1\u20137) in the spontaneously hypertensive rat","volume":"62","author":"Ferrario","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1\u20137): cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/10.4.497","article-title":"Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease","volume":"10","author":"Gansevoort","year":"1995","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(85)90766-6","article-title":"Central and peripheral sites for cardiovascular actions of dynorphin-(1\u201313) in rats","volume":"111","author":"Gautret","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib75","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.091415198","article-title":"A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function","volume":"98","author":"Giordano","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj20021842","article-title":"Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme","volume":"371","author":"Gordon","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib77","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib78","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence","volume":"42","author":"Guy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib79","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.HYP.26.4.642","article-title":"Apoptosis in target organs of hypertension","volume":"26","author":"Hamet","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib80","first-page":"15","article-title":"The impact of structure-guided drug design on clinical agents","volume":"3","author":"Hardy","year":"2003","journal-title":"Current Drug Discovery"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib82","first-page":"867","article-title":"Gene therapy for myocardial regeneration","volume":"61","author":"Hayashi","year":"2003","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib83","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/S0895-7061(01)02066-0","article-title":"Gene transfer to blood vessels: a research tool and potential therapy","volume":"14","author":"Heistad","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1152\/physrev.1998.78.4.1055","article-title":"Hibernating myocardium","volume":"78","author":"Heusch","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib85","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.90.3.1328","article-title":"Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats","volume":"90","author":"Heymes","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.RES.69.2.475","article-title":"Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure","volume":"69","author":"Hirsch","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib87","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/01.CIR.94.7.1513","article-title":"Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction","volume":"94","author":"Hokimoto","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib88","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib89","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1074\/jbc.M212934200","article-title":"Novel peptide inhibitors of angiotensin-converting enzyme 2","volume":"278","author":"Huang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib90","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/01.ASN.0000071512.93927.4E","article-title":"Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease","volume":"14","author":"Huang","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib91","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0076-6879(02)46077-6","article-title":"Large-scale production of retroviral vectors for systemic gene delivery","volume":"346","author":"Huentelman","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib92","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/01.HYP.0000146120.29648.36","article-title":"Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor","volume":"44","author":"Huentelman","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2004.05.003","article-title":"Cloning and characterization of a secreted form of angiotensin-converting enzyme 2","volume":"122","author":"Huentelman","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib94","first-page":"147","article-title":"The renin\u2013angiotensin system","volume":"28","author":"Inagami","year":"1994","journal-title":"Essays Biochem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib95","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib97","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.93.18.9960","article-title":"Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense","volume":"93","author":"Iyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.31.1.356","article-title":"Angiotensin-(1\u20137) contributes to the antihypertensive effects of blockade of the renin-angiotensin system","volume":"31","author":"Iyer","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib98","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.HYP.36.3.417","article-title":"Contribution of angiotensin-(1\u20137) to blood pressure regulation in salt-depleted hypertensive rats","volume":"36","author":"Iyer","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib99","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.HYP.0000017283.67962.02","article-title":"Angiotensin 1\u20139 and 1\u20137 release in human heart: role of cathepsin A","volume":"39","author":"Jackman","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1440-1681.1999.03078.x","article-title":"Physiological genetics: application to hypertension research","volume":"26","author":"Jacob","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib101","doi-asserted-by":"crossref","first-page":"II49","DOI":"10.1161\/01.HYP.19.2_Suppl.II49","article-title":"Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors","volume":"19","author":"Jaiswal","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib102","first-page":"664","article-title":"Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved","volume":"265","author":"Jaiswal","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib103","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0008-6363(03)00535-2","article-title":"Impact of chymase inhibitor on cardiac function and survival after myocardial infarction","volume":"60","author":"Jin","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib104","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1089\/hum.1997.8.15-1753","article-title":"Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats","volume":"8","author":"Jin","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib105","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1073\/pnas.131147598","article-title":"Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice","volume":"98","author":"Ju","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib106","first-page":"21","article-title":"ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats","volume":"314","author":"Kaneko","year":"1997","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib107","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-118-2-199301150-00009","article-title":"Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis","volume":"118","author":"Kasiske","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib108","doi-asserted-by":"crossref","first-page":"H1506","DOI":"10.1152\/ajpheart.00270.2003","article-title":"Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion","volume":"285","author":"Kato","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib109","first-page":"H1260","article-title":"Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR","volume":"277","author":"Katovich","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00004872-200109000-00006","article-title":"Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension","volume":"19","author":"Katovich","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib111","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1139\/y02-029","article-title":"Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system","volume":"80","author":"Katugampola","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib112","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmcc.1997.0376","article-title":"Cultured myofibroblasts generate angiotensin peptides de novo","volume":"29","author":"Katwa","year":"1997","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib113","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib114","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/01.CIR.97.18.1848","article-title":"Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop","volume":"97","author":"Kloner","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1291\/hypres.26.759","article-title":"Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy","volume":"26","author":"Koga","year":"2003","journal-title":"Hypertens Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.HYP.17.2.131","article-title":"Angiotensin-(1\u20137). A member of circulating angiotensin peptides","volume":"17","author":"Kohara","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib117","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V86.5.1828.bloodjournal8651828","article-title":"Endothelial-specific gene expression directed by the tie gene promoter in vivo","volume":"86","author":"Korhonen","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib118","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00005344-199806000-00008","article-title":"Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats","volume":"31","author":"Kost","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib119","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1567-5769(02)00022-X","article-title":"Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice","volume":"2","author":"Lagneux","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib121","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.93.20.11035","article-title":"Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog","volume":"93","author":"Lee","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib122","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI316","article-title":"Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell","volume":"101","author":"Leri","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib123","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1389203043379693","article-title":"The peptide hormone angiotensin II: its new functions in tissues and organs","volume":"5","author":"Leung","year":"2004","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib124","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib126","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/01.HYP.29.1.394","article-title":"Angiotensin-(1\u20137) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide","volume":"29","author":"Li","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib127","first-page":"H2313","article-title":"Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat","volume":"272","author":"Li","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib128","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.26.6.847","article-title":"Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats","volume":"26","author":"Lin","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/01.HYP.30.3.307","article-title":"Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery","volume":"30","author":"Lin","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib130","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib131","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib132","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","article-title":"Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats","volume":"105","author":"Loot","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib133","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/07853890109002071","article-title":"Gene therapy for human bypass grafts","volume":"33","author":"Mangi","year":"2001","journal-title":"Ann. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib134","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.0000065619.36118.20","article-title":"Caspase-dependent cell death mediates the early phase of aortic hypertrophy regression in losartan-treated spontaneously hypertensive rats","volume":"92","author":"Marchand","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-7793.2001.0069m.x","article-title":"Endothelial kinin B(1)-receptors are induced by myocardial ischaemia-reperfusion in the rabbit","volume":"530","author":"Mazenot","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib137","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib138","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1161\/01.CIR.0000037125.61227.68","article-title":"Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats","volume":"106","author":"McMurray","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib139","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1096\/fj.03-1171rev","article-title":"Gene and cell-based therapies for heart disease","volume":"18","author":"Melo","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib140","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.HYP.0000127563.14064.fd","article-title":"Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer","volume":"43","author":"Metcalfe","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib141","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-1-4757-3401-0_26","article-title":"Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human models","volume":"502","author":"Michelakis","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib142","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.STR.27.11.2033","article-title":"Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects","volume":"27","author":"Miettinen","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib143","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb06340.x","article-title":"Gene therapy for cardiovascular disease using hepatocyte growth factor","volume":"902","author":"Morishita","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib144","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00063030-200317060-00001","article-title":"Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease","volume":"17","author":"Morishita","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1126\/science.287.5452.488","article-title":"Transgenic mouse model of stunned myocardium","volume":"287","author":"Murphy","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib146","first-page":"388","article-title":"Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells","volume":"284","author":"Muthalif","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib147","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature01370","article-title":"Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib148","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0002-8703(92)90610-8","article-title":"Heredity and hypertension: impact on metabolic characteristics","volume":"124","author":"Neutel","year":"1992","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib149","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1172\/JCI118366","article-title":"Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation","volume":"96","author":"Niimura","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/hc0302.102618","article-title":"The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/snep.2002.2002.30434","article-title":"Genetics of programmed cell death and proliferation","volume":"22","author":"Orlov","year":"2002","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib153","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.86.11.1167","article-title":"Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense","volume":"86","author":"Pachori","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib152","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.0000017827.63253.16","article-title":"Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy","volume":"39","author":"Pachori","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib154","doi-asserted-by":"crossref","first-page":"12282","DOI":"10.1073\/pnas.0404616101","article-title":"Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia\/reperfusion tissue injury","volume":"101","author":"Pachori","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.0.0740251","article-title":"Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man","volume":"74","author":"Padfield","year":"1977","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib156","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.23.7.888","article-title":"Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes","volume":"23","author":"Pahor","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib157","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(98)00208-3","article-title":"Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection","volume":"105","author":"Parmley","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib158","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/1056-8727(96)00031-1","article-title":"Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy","volume":"10","author":"Parving","year":"1996","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib159","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib160","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.HYP.26.6.1154","article-title":"Angiotensin-(1\u20137) potentiates the hypotensive effect of bradykinin in conscious rats","volume":"26","author":"Paula","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib161","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib162","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib163","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/14712598.1.4.655","article-title":"Gene therapy for hypertension: sense and antisense strategies","volume":"1","author":"Phillips","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib164","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/hy09t1.092927","article-title":"Gene therapy for hypertension: the preclinical data","volume":"38","author":"Phillips","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/hy0202.103472","article-title":"Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection","volume":"39","author":"Phillips","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib166","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib167","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib168","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1476-5381.1994.tb14787.x","article-title":"Release of nitric oxide by angiotensin-(1\u20137) from porcine coronary endothelium: implications for a novel angiotensin receptor","volume":"111","author":"Porsti","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib169","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2003-01-0167","article-title":"Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion","volume":"102","author":"Powell","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0163-7258(02)00165-1","article-title":"The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system","volume":"93","author":"Pugsley","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib171","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1345\/aph.17388","article-title":"ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema","volume":"32","author":"Pylypchuk","year":"1998","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib172","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200018040-00001","article-title":"Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension","volume":"18","author":"Raizada","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib173","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib174","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib175","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.2001.00320.x","article-title":"Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain","volume":"77","author":"Reaux","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib176","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/S0021-9258(18)34171-1","article-title":"Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases","volume":"257","author":"Reilly","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib177","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/hy0302.104673","article-title":"Vasodilator action of angiotensin-(1\u20137) on isolated rabbit afferent arterioles","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib178","doi-asserted-by":"crossref","first-page":"26765","DOI":"10.1016\/S0021-9258(19)61441-9","article-title":"Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells","volume":"275","author":"Richard","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"Suppl 7","key":"10.1016\/j.pbiomolbio.2005.05.011_bib179","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00005344-198706107-00007","article-title":"Converting enzyme inhibitors in the treatment of hypertension","volume":"10","author":"Robertson","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.34.2.296","article-title":"Angiotensin-(1\u20137) is a modulator of the human renin\u2013angiotensin system","volume":"34","author":"Roks","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib181","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.CIR.91.1.16","article-title":"Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy","volume":"91","author":"Ruzicka","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib182","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.CIR.53.3.400","article-title":"The role of the renin\u2013angiotensin\u2013aldosterone system in cardiovascular homeostasis in normal human subjects","volume":"53","author":"Sancho","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib183","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib184","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI114924","article-title":"Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation","volume":"86","author":"Schunkert","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.87.4.1328","article-title":"Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts","volume":"87","author":"Schunkert","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200107000-00001","article-title":"Gene therapy to control hypertension: current studies and future perspectives","volume":"322","author":"Sellers","year":"2001","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib187","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1527-5299.2004.02806.x","article-title":"ACE inhibitor intolerance and lessons learned from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) trials","volume":"10","author":"Sica","year":"2004","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib188","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9149(99)00727-4","article-title":"Angiotensin II receptor blockers: review of the binding characteristics","volume":"84","author":"Siragy","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib189","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.103.3.295","article-title":"The preparation and function of the hypertensin-converting enzyme","volume":"103","author":"Skeggs","year":"1956","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.pbiomolbio.2005.05.011_bib190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000176938","article-title":"Local renin-angiotensin systems in cardiovascular tissues: localization and functional role","volume":"86","author":"Stock","year":"1995","journal-title":"Cardiology"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib191","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1101\/gr.10.4.473","article-title":"New target regions for human hypertension via comparative genomics","volume":"10","author":"Stoll","year":"2000","journal-title":"Genome Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib192","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1126\/science.1062117","article-title":"A genomic-systems biology map for cardiovascular function","volume":"294","author":"Stoll","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib193","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.HYP.33.1.207","article-title":"Angiotensin-(1\u20137) reduces smooth muscle growth after vascular injury","volume":"33","author":"Strawn","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib194","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1161\/01.CIR.101.15.1848","article-title":"Stimulation of bradykinin B(1) receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B(2) receptor stimulation","volume":"101","author":"Su","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib195","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1006\/jmcc.2001.1365","article-title":"Renin expression at sites of repair in the infarcted rat heart","volume":"33","author":"Sun","year":"2001","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib196","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-199917080-00022","article-title":"Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats","volume":"17","author":"Susic","year":"1999","journal-title":"J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib197","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib198","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","article-title":"The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats","volume":"291","author":"Taheri","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib199","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.HYP.34.4.950","article-title":"State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1\u20137) in vascular smooth muscle","volume":"34","author":"Tallant","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1046-2023(02)00231-1","article-title":"Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases","volume":"28","author":"Tang","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib201","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1039\/b314510g","article-title":"High-throughput protein crystallography and drug discovery","volume":"33","author":"Tickle","year":"2004","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib202","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib203","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)09374-X","article-title":"Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation","volume":"354","author":"Torp-Pedersen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signaling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib206","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib207","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","article-title":"The angiotensin-converting enzyme gene family: genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib208","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.HYP.35.4.998","article-title":"Angiotensin-(1\u20137) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man","volume":"35","author":"Ueda","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib209","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1359-6446(02)02233-X","article-title":"Structure-based screening and design in drug discovery","volume":"7","author":"van Dongen","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib211","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.HYP.37.6.1399","article-title":"Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors","volume":"37","author":"Varagic","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib212","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.RES.70.1.66","article-title":"Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons","volume":"70","author":"Ventura","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib213","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib214","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/mthe.2002.0542","article-title":"Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors","volume":"5","author":"Vigna","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0735-1097(96)00440-8","article-title":"Age dependency of left ventricular diastolic function in pressure overload hypertrophy","volume":"29","author":"Villari","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib216","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.RES.85.7.614","article-title":"Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA","volume":"85","author":"Wang","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib217","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/sj.gt.3302294","article-title":"Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries","volume":"11","author":"Wang","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib218","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1007\/s00018-004-4240-7","article-title":"Angiotensin-converting enzyme-2: a molecular and cellular perspective","volume":"61","author":"Warner","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib219","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib220","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/0002-9343(91)90057-5","article-title":"Cardiovascular and metabolic characteristics of hypertension","volume":"91","author":"Weber","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib221","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0024-3205(93)90108-F","article-title":"A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11","volume":"52","author":"Welches","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib222","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/PL00005265","article-title":"Diminution of contractile response by kappa-opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein","volume":"358","author":"Wenzlaff","year":"1998","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib223","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.0000109697.68832.5D","article-title":"Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors","volume":"109","author":"White","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib224","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.HYP.0000063886.71596.C8","article-title":"Hypothesis: ACE2 modulates blood pressure in the mammalian organism","volume":"41","author":"Yagil","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-0115(99)00005-1","article-title":"Differential response of angiotensin peptides in the urine of hypertensive animals","volume":"80","author":"Yamada","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib226","first-page":"L127","article-title":"Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury","volume":"277","author":"Yang","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib227","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ki.1989.35","article-title":"Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis","volume":"35","author":"Yoshida","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib228","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib229","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1074\/jbc.M006723200","article-title":"Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib230","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00004872-198412000-00002","article-title":"Interaction between sympathetic and renin-angiotensin system","volume":"2","author":"Zimmerman","year":"1984","journal-title":"J. Hypertens."},{"key":"10.1016\/j.pbiomolbio.2005.05.011_bib231","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","article-title":"Increased angiotensin-(1\u20137)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610705000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610705000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T03:10:52Z","timestamp":1728529852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610705000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":231,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0079610705000209"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2005.05.011","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACE2: A novel therapeutic target for cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2005.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}